Please assess the completion status of the following clinical trial:

Trial Title: Acupuncture for Joint Symptoms in Patients With Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. BC patients with a confirmed diagnosis of hormone receptor-positive BC at the stage of I, II or IIIa;~2. Patients who have completed taxane-based chemotherapy and are currently undergoing hormone treatments for at least three months;~3. Patients indicate ongoing joint symptoms, including joint pain and/or stiffness, at one or more sites of body;~4. Patients started to experience the joint symptoms after the commencement of the hormone treatments;~5. Patients indicate the intensity of their worst pain during the past seven days of greater than 4 points at a 0-10 NRS scale where 0 represents no pain and 10 indicates most severe pain;~6. Patients have at least a primary school education and are able to communicate in Chinese Mandarin or Sichuanese; and~7. Patients agree to participate in the trial and are willing to give written informed consent.~Exclusion Criteria:~1. Patients who had needle phobia and a low count of platelet of less than 50,000;~2. Patients with conditions which are not appropriate for acupuncture including pregnancy, bleeding disorders, local or systematic inflammation, and other neuropathic and/or metabolic problems of the joints;~3. Patients who had received joint surgery or had bone fracture during the past six months;~4. Patients who had received any types of acupoint stimulation (e.g. body acupuncture or acupressure and auricular therapy) during the past six months; and~5. Patients are currently treated with narcotic analgesia or steroids.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- True Acupuncture (Type: EXPERIMENTAL): Patients in the experimental group will receive, in addition to standard care, a standardised 30-minute acupuncture session needling specific acupoints. Bilateral acupoints will be stimulated including Waiguan (SJ5), Jianjing (GB21), Yanglingquan (GB34), Hegu (LI4), Jiexi (ST41) and Taixi (K3). In addition, joint specific acupoints will also be used, depending on where the joint symptoms are present.
- Sham Acupuncture (Type: SHAM_COMPARATOR): In addition to the routine methods of care, patients allocated to the sham control group will receive sham acupuncture treatment at sham acupoints with superficial needling
- Standard Control Group (Type: NO_INTERVENTION): The third arm will be a standard care control arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).